Chemotherapy for gallbladder carcinoma - A surgeon's perspective

Hepato-Gastroenterology

Volumn 47, Issue 34, 2000, Pages 948-955

  Todoroki, T ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Adjuvant chemotherapy; Gallbladder cancer; Postoperative and preoperative chemotherapy; Preoperative induction chemotherapy; Systemic and hepatic arterial infusion chemotherapy

Indexed keywords

AMSACRINE; ANTHRACYCLINE DERIVATIVE; BIOLOGICAL RESPONSE MODIFIER; CARBOQUONE; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EMETINE; EPIRUBICIN; ETOPOSIDE; FLOXURIDINE; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; HYDROXYUREA; METHOTREXATE; MITOMYCIN C; NITROSOUREA DERIVATIVE; RECOMBINANT INTERFERON; RUFOCROMOMYCIN; SEMUSTINE; STREPTOZOCIN; TAXOL; TEGAFUR; THIOTEPA; UFT; UNINDEXED DRUG; VINCRISTINE;

BILE DUCT; BLOOD TOXICITY; BONE MARROW TOXICITY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER SURGERY; CLINICAL TRIAL; DIARRHEA; DRUG ADMINISTRATION; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; GALLBLADDER CARCINOMA; HUMAN; METASTASIS; MINIMAL RESIDUAL DISEASE; NAUSEA; PANCYTOPENIA; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; REVIEW; THROMBOCYTOPENIA; VOMITING;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; GALLBLADDER NEOPLASMS; HUMAN; INFUSIONS, INTRA-ARTERIAL; PREOPERATIVE CARE; SUPPORT, NON-U.S. GOV'T;

EID: 0033807872     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Chemotherapy of Cancer Mitomycin C
2. The gallbladder
3. Adenocarcinomas of stomach, pancreas, liver, and biliary tracts
4. Mitomycin C in advanced gallbladder carcinoma
5. Phase II trial of m-AMSA in gallbladder and cholangiocarcinoma: A Southwest Oncology Group study
6. Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gallbladder and bile duct cancer
7. Chemotherapy for unresectable biliary cancer
8. Phase II trial of mitomycin C (MMC) in advanced gallbladder and biliary tree carcinoma. An EORTC Gastrointestinal Tract Cancer Cooperative Group Study
9. A Phase II study of cisplatin in patients with biliary tract carcinoma
10. Phase II study of paclitaxel therapy for unresectable biliary tree carcinomas
11. Pharmacokinetics of Mitomycin C in Humans
12. Superselective intra-arterial chemotherapy with mitomycin for gallbladder cancer
13. Killing effects of 5-fluorouracil on human biliary tract cancer cell lines
14. A case of gallbladder cancer successfully treated with UFTM therapy
15. MQF-FT and MQF-UFT in gallbladder and bile duct cancer
16. A case of gallbladder cancer with marked response to EAP treatment
17. Epirubicin-sequential methotrexate-5-fluorouracil-leucovorin treatment in advanced cancer of the extrahepatic biliary system. A phase II study
18. Epirubicin: Cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumours
19. Oral chemotherapy with doxifluridine and folinic acid in biliary tract cancer
20. Pilot study of ambulatory infusional delivery of a multidrug regimen: Cisplatin, 5-fluorouracil and leucovorin (PFL) +/- etoposide
21. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.)
22. Clinical effect of immunochemotherapy for a patient with advanced gallbladder cancer: Report of a case
23. A phase II study of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinoma
24. 5-Fluorouracil, mitomycin, and doxorubicin (FAM) in carcinoma of the biliary tract
25. The influence of methotrexate pretreatment on 5-fluorouracil metabolism in L1210
26. Biochemical determinants of responsiveness to 5-fluorouracil and its derivatives in xenografts of human colorectal adenocarcinomas in mice
27. Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells
28. Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts
29. Phase II trial of intervenous fluorouracil and subcutaneous interferon alfa-2b for biliary tract cancer
30. Intrahepatic arterial infusion of combination of mitomycin-C and 5-fluorouracil in treatment of primary and metastatic liver carcinoma
31. Arterial infusion of combination chemotherapy using adriamycin and mitomycin C for hepatoma and metastatic tumor of the liver
32. Hepatic artery infusion of 5-fluorouracil and mitomycin C in cholangiocarcinoma and gallbladder carcinoma
33. Superselective intra-arterial chemotherapy with mitomycin for gallbladder cancer
34. Clinical and pharmacological study of intrahepatic artery infusion of thiotepa
35. Two cases of improved quality of life with intra-arterial infusion of CDDP or unresectable gallbladder and pancreatic cancer
36. Evaluation of arterial infusion chemotherapy for advanced gallbladder cancer using implantable port
37. Study of hepatic arterial chemoinfusion with continuous CDDP, 5-FU low dose administration for advanced gallbladder cancer
38. Primary carcinoma of the gallbladder. The role of adjunctive therapy in its treatment
39. Effectiveness of chemotherapy in addition to surgery in treating carcinoma of the gallbladder
40. Intraductal chemotherapy for biliary tract malignancy
41. Primary gallbladder carcinoma: Significance of subserosal lesions and results of aggressive surgical treatment and adjuvant chemotherapy
42. Advanced gallbladder carcinoma: A case report and review of the literature
43. Superselective intra-arterial chemotherapy with mitomycin C in liver and gallbladder cancer
44. Carcinoma of the gallbladder: Review of the literature and report on 56 cases at the Beth Israel Medical Center
45. Efficacy of 48-hour infusion of 5-fluorouracil for gallbladder cancer
46. Superselective intra-arterial chemotherapy with mitomycin C in hepatic neoplasms
47. Efficacy of gemcitabine in the treatment of patients with gallbladder carcinoma: A case report
48. A case of retroperitoneal lymph node recurrence with gallbladder cancer responding to UFT and CDDP combination chemotherapy
49. Lymph node recurrence of gallbladder carcinoma successfully managed by systemic chemotherapy with 5-fluorouracil and mitomycin C: Report of a 5-year survivor
50. A case of recurrent gallbladder cancer with marked response to arterial infusion chemotherapy and transarterial embolization
51. Induction chemotherapy via hepatic artery for gallbladder carcinoma
52. A Case of unresectable advanced cancer of the gallbladder successfully treated by arterial infusion therapy with cisplatin
53. A case of advanced gallbladder cancer responding to neoadjuvant intra-arterial chemotherapy